Aspirin to Prevent Ppregnancy-Induced Hypertension

To the Editor: The report by Schiff et al. (Aug. 10 issue)* regarding the prevention of ppregnancy-induced hypertension through the use of low-dose aspirin is very exciting. As the authors state, aspirin has effects on thromboxane production as well as platelet function in general. In their study, 14.7 percent of the women in the treated group had cesarean deliveries, as compared with 29.0 percent in the placebo group and 10.6 percent in the low-risk control group. Anticipating the widespread use of this therapy and knowing its effects on platelets and the risks of transfusion, we would be very interested in . . .